A multicentre, retrospective study analysing demographic and clinical features and treatment outcomes of Chronic Phase Chronic Myeloid Leukemia Patients in Turkey
Latest Information Update: 22 Jul 2020
At a glance
- Drugs Dasatinib (Primary) ; Imatinib (Primary) ; Nilotinib (Primary) ; Ponatinib (Primary)
- Indications Chronic myeloid leukaemia
- Focus Adverse reactions; Therapeutic Use
- 22 Jul 2020 New trial record
- 21 Jun 2020 Results presented at the 25th Congress of the European Haematology Association